Wed, September 7, 2022
Tue, September 6, 2022
Mon, September 5, 2022
Fri, September 2, 2022
Thu, September 1, 2022
Wed, August 31, 2022
Tue, August 30, 2022
Mon, August 29, 2022
Sun, August 28, 2022
Fri, August 26, 2022
Thu, August 25, 2022
Wed, August 24, 2022
Tue, August 23, 2022

Caroline Palomeque Initiated (ASND) at Strong Buy and Held Target at $166 on, Aug 30th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-166-on-aug-30th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Caroline Palomeque of Berenberg, Initiated "Ascendis Pharma A/S" (ASND) at Strong Buy and Held Target at $166 on, Aug 30th, 2022.

Caroline has made no other calls on ASND in the last 4 months.



There are 6 other peers that have a rating on ASND. Out of the 6 peers that are also analyzing ASND, 0 agree with Caroline's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Caroline


  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $168 on, Thursday, August 11th, 2022
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $144 on, Thursday, August 11th, 2022
  • Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $148 on, Thursday, August 11th, 2022
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $123 on, Thursday, May 12th, 2022
  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $158 on, Thursday, May 12th, 2022
  • Derek Archila of "Wells Fargo" Maintained at Buy with Decreased Target to $176 on, Thursday, May 12th, 2022

Publication Contributing Sources